314 DISEASES/DISORDERS
DIAGNOSTICS
CBC: nonregenerative anemia may occur with severe disease.
Serum chemistries: creatine kinase may be normal or slightly high.
ANA titers and lupus erythematosus tests negative.
EMG: abnormalities in affected muscles; fibrillation potentials; bizarre high-
frequency discharges; positive sharp waves.
Muscle biopsy: difficult because pathologic changes may be mild, multifocal, or (in
early states) absent; ideally, use EMG to select affected muscles; otherwise, biopsy
atrophied muscles:
Variable multifocal accumulations of inflammatory cells, including lymphocytes,
macrophages, plasma cells, neutrophils, and eosinophils
Myofibril degeneration characterized by fragmentation, vacuolation, and
increased eosinophilia of the myofibrils
Myofiber atrophy and regeneration.
Skin biopsy: choose papules, vesicles, or lesions that show alopecia and erythema;
avoid infected and scarred lesions:
Scattered necrotic basal cells (colloid bodies) or vacuolated individual basal cells
Occasionally, vesicles that contain small amounts of RBCs
Superficial, mild, diffuse dermal inflammatory infiltrates composed of lympho-
cytes and histiocytes with variable numbers of mast cells and neutrophils (espe-
cially perifollicular)
Follicular basal cell degeneration and follicular atrophy
Secondary epidermal ulceration and dermal scarring
Combination of perifollicular inflammation, epidermal and follicular cell degen-
eration, and follicular atrophy strongly supports the diagnosis.
THERAPEUTICS
Nonspecific symptomatic therapy, including gentle soakings of crusts and treatment
of secondary pyoderma.
Avoid activities that may traumatize the skin.
Keep indoors during the day to avoid exposure to intense sunlight.
Estrus may exacerbate the disease; neutering intact females is recommended.
Drugs of Choice
Therapeutic efficacy of medical treatment can be difficult to assess because the disease
tends to be cyclic and is often self-limiting.
Vitamin E: 100–400 IU PO BID to q24h.
Prednisolone: 1–2 mg/kg PO BID until remission; then alternate-day administration;
use the lowest dosage possible for long-term control.